As of 05/21/2025, Iterum Therapeutics plc's market capitalization has reached $38.09 M. According to our data, Iterum Therapeutics plc is the 31389th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap
38.09 M
Revenue (ttm)
0
Net Income (ttm)
-22,564,000
Shares Out
40 M
EPS (ttm)
-0.93
Forward PE
0.00
Ex-Dividend Date
n/a
Earnings Date
05/13/2025
Market Cap Chart
Data Updated: 05/21/2025
Iterum Therapeutics plc's yearly market capitalization.
Iterum Therapeutics plc has seen its market value drop from $48.54 M to $38.09 M since 2020, representing a total decrease of 21.53% and an annual compound decline rate (CAGR) of 5.38%.
Date
Market Cap
Change (%)
05/21/2025
$38.09 M
-27.58%
12/31/2024
$48.70 M
84.01%
12/29/2023
$26.47 M
157.57%
12/30/2022
$10.28 M
-85.65%
12/31/2021
$71.61 M
47.53%
12/31/2020
$48.54 M
Company Profile
Iterum Therapeutics plc was founded in 2015 in Ireland.
The company went public on 05/25/2018
on the Nasdaq Stock Market.
With 9 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
As of 05/21/2025, Iterum Therapeutics plc (including the parent company, if applicable) has an estimated market capitalization of $38.09 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Iterum Therapeutics plc global market capitalization ranking is approximately 31389 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.